Gout imaging showdown: ultrasound vs. DECT in 60 patients
NCT ID NCT03162341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well two types of imaging—ultrasound and dual-energy CT (DECT)—agree when measuring urate crystal deposits in people with gout. Sixty adults starting urate-lowering therapy were scanned at the start and again after 6, 12, and 24 months. The goal was to see if the two methods give similar results for tracking changes in deposit size over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bichat Hospital
Paris, 75018, France
-
Hospital Group of the Catholic Institute
Lomme, 59462, France
-
Lariboisière Hospital
Paris, 75475, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to tame stubborn gout flares
- Timing matters: study tests if starting gout drug during a flare is safe
- Ultrasound may solve arthritis diagnosis puzzle
- Probiotic supplement shows promise for gout prevention in small study
- New gout drug dotinurad shows promise in early trial
- Why is gout so common in polynesians? scientists look to genes for answers